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1166-213 Computed Tomography Guided Evaluation of 
Pulmonary Vein Anatomy Following Percutaneous 
Cryoablation: 12-Month Results
David Szapiro, Benoit Ghaye, Carl Timmermans, Robert F. Dondelinger, Hung-Fat Tse, 
Christoph Geller, Gregory Ayers, Luz-Maria Rodriguez, Chu Liege, Liege, Belgium, 
Academic Hospital Maastricht, Maastricht, The Netherlands
BACKGROUND: Pulmonary vein isolation (PVI), using radiofrequency energy, for treat-
ment of atrial fibrillation (AF) has been associated with complications including pulmo-
nary vein (PV) stenosis or thrombosis. The purpose of this study was to prospectively
evaluate the PV anatomy following cryoablation.
METHODS: 50 patients underwent percutaneous PVI in 3 academic centres. Contrast-
enhanced, single-slice or multi-slice spiral CT (1-2.5 mm thick slices) was obtained
before, 3 and 12 months following PVI. All examinations were read blinded to the loca-
tion(s) of ablation. PVs were evaluated quantitatively and qualitatively: the diameter at
ostium and at 1 cm from ostium were measured. The presence and location of luminal
irregularity or thrombosis was also assessed.
RESULTS: In ablated veins, the mean diameters at ostium were right inferior PV
1.58±0.34, 1.55±0.29 and 1.66±0.15 cm, right upper PV 1.59 ±0.22, 1.53 ±0.24 and
1.47±0.26 cm, left inferior PV 1.29±0.33, 1.24±0.33 and 1.13±0.25 cm, left upper PV
1.73±0.38, 1.70±0.36 and 1.67±0.35 cm before the procedure and, 3 and 12 months
after the procedure respectively. No significant difference (p > 0.05) was found between
diameter in ablated versus not ablated veins before and after the procedure. Three
patients presented with luminal irregularity before the procedure. No patient showed
luminal irregularity or thrombosis of PV following cryo-ablation.
CONCLUSION: These results suggest that PVI for the treatment of AF is not associated
with stenosis or thrombosis of cryoablated PVs after one year follow-up.
1166-214 Usefulness of a Ventricular Extrastimulus From the 
Summit of the Ventricular Septum in Diagnosis of 
Septal Accessory Pathway
Takehiko Matsushita, Nitish Badhwar, Kathryn K. Collins, George F. Van Hare, Byron K. 
Lee, Randall J. Lee, Melvin M. Scheinman, University of California, San Francisco, San 
Francisco, CA
Background: A ventricular extrastimulus (VES) delivered when the His bundle is refrac-
tory that advances the subsequent atrial deflection proves the existence of an accessory
pathway (AP). Moreover, a VES delivered during His bundle refractoriness which termi-
nates the tachycardia without succeeding atrial activation proves participation of the AP
in the tachycardia circuit. The purpose of the study was to compare delivery of a VES
from the right ventricular (RV) apex versus the summit of the RV septum in patients with
a single septal AP.
Methods: In a retrospective analysis of 16 consecutive patients with a septal AP, a VES
from the RV apex delivered at the time of His deflection during tachycardia resulted in
advancement of the succeeding atrial deflection in 5 and terminated the tachycardia with-
out subsequent atrial depolarization in 2 patients. We prospectively analyzed the data in
a separate group of 12 patients with a septal AP in which a VES was delivered from the
RV apex and then from the RV summit at the time of His deflection during tachycardia.
Results: RV apical VES advanced the succeeding atrial deflection in 3 patients and ter-
minated the tachycardia in another 3 patients. In contrast, RV summit VES advanced the
succeeding atrial deflection in 4 and terminated the tachycardia in 6 patients. RV summit
VES resulted in a significantly higher diagnostic yield for the presence of a septal AP
compared with RV apical VES (83% vs. 46%, P <0.05). RV summit VES also resulted in
a higher diagnostic yield for proof of participation of a septal AP in the tachycardia circuit
compared with RV apical VES (50% vs. 18%, P <0.05). A VES from the RV summit was
diagnostic of presence of an AP in all patients with a right-sided septal AP but in only 1
out of 3 patients with a left posteroseptal AP.
Conclusion: A VES during His bundle refractoriness from the RV summit increases the
diagnostic yield for both presence of an AP and its participation in the tachycardia circuit
with respect to RV apical VES.
1166-215 Atrial Fibrillation Surgery in Patients With Coronary 
Artery Disease
Thomas Deneke, Krishna Khargi, Peter H. Grewe, Thomas Lawo, Frank Kuschkowitz, 
Bernd Calcum, Axel Laczkovics, Andreas Mügge, Bernd Lemke, University of Bochum, 
Bochum, Germany
Atrial fibrillation (AF) is known to be a risk factor for quality of life and increased mortality.
Patients with coronary artery disease undergoing open heart bypass surgery (CABG)
often have associated AF. Is antiarrhythmic surgery in patients undergoing CABG safe
and effective and is there a subgroup of patients who will benefit most?
Methods: 52 consecutive patients (ejection fraction 54±15%, age 69±7years) with
chronic permanent AF (11±10years) underwent CABG (only CABG in 32, CABG plus
mitral valve surgery in 20 due to ischemic mitral valve insufficiency) plus additional intra-
operative cooled-tip radiofrequency ablation to treat AF (aortic clamp 98±22minutes,
bypass time 164±41minutes) treating the left atrium alone in 26 and both atria in 26
patients.
Results: Out of the total of 52 patients 39 converted to stable sinusrhythm (SR) during a
mean follow-up of 23±16months ranking up to a 12-month estimated rhythm-success
percentage of 80% (3 months 31/44 patients: 70%, 6 months 35/44 patients: 80%, 12
months 28/36 patients: 78%). At 6 months follow-up 79% of patients in SR had docu-
mented biatrial contraction. There is no significant difference in rhythm outcome when
one or both atria are treated (86% versus 75%, p=0.24). During follow-up up 9 patients
died (30-day mortality 8%) ranking up to a cumulative 12-months survival rate of 85%.
Patients undergoing CABG procedure alone had a significantly higher survival in short
and long term follow-up compared to patients undergoing additional mitral valve surgery
(30-day mortality 3% versus 15%, p=0.038; 12-month survival 94% versus 70%,
p=0.049). Conversion rates did not differ significantly in between the two groups (74%
versus 94%, p=0.31).
Conclusions: Intraoperative cooled-tip radiofrequency ablation in the atria can safely and
effectively be added to an open heart surgery in patients with coronary artery disease
and the ablation procedure is equally effective independent to the number of atria treated
(left versus biatrial). Patients with additional mitral valve disease have a worse outcome
in regard to survival but not when considering rhythm outcome. In over 60% of these
patients an anticoagulation regimen may be stopped.
1166-216 Efficacy of Cryoablation for Treatment of Paroxysmal 
Atrial Fibrillation
Hugh Calkins, Mark Wood, Emile Daoud, Neil Kay, Greg Feld, Robert Hoyt, Johns 
Hopkins, Baltimore, MD
Background: Electrical isolation of the pulmonary veins (PV) by radiofrequency catheter
ablation (RFCA) has been shown to be an effective treatment for paroxysmal atrial fibril-
lation (PAF). However, RFCA has been associated with a significant incidence of PV
stenosis. Experimental and early clinical studies have shown that catheter cryoablation of
the PVs is also effective in curing PAF, but without causing PV stenosis.
Methods: Therefore, we performed PV cryoablation using a 10Fr cryoablation catheter
system (CryoCor, Inc) in 31 patients (pts), of whom 23 were males, mean age 56±9 yrs
with drug refractory PAF (failure of 2.1±1.1 drugs pre-procedure) Of these pts, 8 also had
a history of atrial flutter (AFL). All pts underwent map-guided, segmental, pulmonary vein
isolation, with success defined as complete elimination of PV potentials. Event recording,
both symptomatic and scheduled, was used to capture arrhythmia episodes prior to and
for 6 months following cryoablation. Patients underwent spiral CT scans to evaluate PV
diameter at baseline, 3 and 6 months after ablation.
Results: There were 29/31 pts (94%) successfully treated in the index procedure with 86
of 90 veins ablated (96%). At 6 months follow-up there were 13/23 pts (57%) without
recurrence of PAF. Of the 10 pts with recurrent AF, 5 pts had a second ablation using RF
at 2.8±0.87 months. During the 6 months following the index procedure the average fre-
quency of AF episode in RF re-treated pts was 0.94±1.0/month, whereas the average
frequency of AF episodes of those not re-treated was 0.9±1.2/month. In the 13 pts in
sinus at 6 months, 8 were on anti-arrhythmic drugs, 2 of whom were on beta-blockers
only. Of the 23 pts who underwent spiral CT scan at 6 months, none had PV stenosis.
Conclusion: The initial results of this pilot study show that cryoablation can be used as a
single treatment for PAF with 6-month efficacy of 57%. Cryoablation appears to be with-
out risk of PV stenosis.
1166-217 Lone Atrial Fibrillation: A Benign Disease? Data of the 
RACE Study
Michiel Rienstra, Vincent E. Hagens, Hans A. Bosker, Otto Kamp, J. Herre Kingma, Harry 
J. Crijns, Isabelle C. Van Gelder, The RACE Investigators, University Hospital Groningen, 
Groningen, The Netherlands
Background - In patients with persistent atrial fibrillation (AF) rate control is not inferior
to rhythm control regarding morbidity and mortality. With lone AF, outcome of a rate and
rhythm control strategy may differ from that in patients with AF in the setting of underlying
heart disease (UHD). The aim of this study was to compare morbidity, mortality and qual-
ity of life (QoL) under rate or rhythm control in patients with lone AF and AF in UHD.
Methods - In the RAte versus Electrical cardioversion (RACE) study, 522 patients were
randomized to rate or rhythm control. A total of 108 patients had lone AF. The occurrence
of cardiovascular endpoints (components see table) and QoL (using SF-36 question-
naire) were compared between patients with and without UHD.
Results - Patients with lone AF were younger (66±10 vs 69±8 years, p=0.001), suffered
for a shorter period from AF (p=0.004) and had less complaints of fatigue (p=0.02) and
dyspnea (p=0.000) compared to those with UHD. With lone AF, QoL at baseline was
higher. Mean follow-up was 2.3±0.6 years. Cardiovascular endpoints occurred in 9% (10)
of the patients with lone AF, 7 under rate and 3 under rhythm control, and in 23% (94) of
the patients with UHD. QoL did not largely change in both groups towards study end.
